Stockscreener 앱 받기
182.34
1.33%
-2.45
시장 영업 전:
182.34
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
LH vs. CRL: Which Stock Is the Better Value Option? - Yahoo Finance
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Charles River Laboratories Stock (US1591881009): shares in focus after recent earnings and valuation - AD HOC NEWS
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down - MSN
Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears - Insider Monkey
Top Charles River Laboratories International (CRL) Competitors 2026 - MarketBeat
Convert Charles River Laboratories International, Inc. (CRL) to New Taiwan dollar (TWD) - Crypto.com
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Assessing Charles River Laboratories (CRL) Valuation After Recent Share Recovery And Conflicting Fair Value Signals - simplywall.st
Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE) - The Globe and Mail
Charles River (NYSE: CRL) director James C. Foster reports 366,722-share gift and trust transfers - Stock Titan
CRL (CRL) CEO shifts 6,772 shares via bona fide gifts, keeps large stake - Stock Titan
Charles River (NYSE: CRL) exec reports 3,058-share stock gifts and positions - Stock Titan
RBC Capital Keeps Their Buy Rating on Charles River Labs (CRL) - The Globe and Mail
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN
CRL Q1 2026 Earnings: EPS Surpasses Estimates, Stock Retreats Despite Profit BeatEstimate Uncertainty - newsline.com
Charles River Laboratories (CRL) Slips 2.4% as Key Support Levels LoomSwing Entry Signals - newsline.com
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Can Charles River’s Portfolio Divestitures and “Pathway to Purpose” Strategy Reframe the CRL Investment Narrative? - simplywall.st
Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says - marketscreener.com
Assessing Charles River Laboratories (CRL) Valuation After Mixed Returns And Contrasting Undervaluation Signals - Yahoo Finance
Charles River (CRL) director awarded 422 restricted stock units as fees - Stock Titan
CRL: New strategy targets margin gains, tech integration, and growth, with DSA momentum building - TradingView
Charles River Laboratories International Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow (NYSE:CRL) 2026-06-03 - Seeking Alpha
Charles River Laboratories International Inc (CRL) Shares Fall 4 - GuruFocus
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
CRL (CRL) CFO Glenn Coleman receives 6,640-share equity grant at $180.71 - Stock Titan
CRL (NYSE: CRL) CIO receives stock grant; shares withheld for taxes - Stock Titan
Charles River (NYSE: CRL) EVP awarded 5,257 shares, 979 withheld - Stock Titan
CRL (NYSE: CRL) SVP Michael Knell awarded 1,837 shares, 200 used for tax withholding - Stock Titan
Charles River (NYSE: CRL) CEO awarded shares, withholds stock to pay tax - Stock Titan
James C. Foster (CRL) records tax-withholding share disposition and updates indirect holdings - Stock Titan
Charles River (NYSE: CRL) EVP gets 5,135-share award with tax withholding - Stock Titan
Charles River (NYSE: CRL) executive reports stock grant and tax withholding - Stock Titan
CRL: Operational efficiency, innovation, and portfolio focus drive growth and resilience - TradingView
CRL: Modernization, AI, and NAMs drive growth and margin expansion, with renewed DSA momentum - TradingView
Charles River Laboratories International Inc at William Blair Growth Stock Conference Transcript - GuruFocus
Charles River Shareholder Notice - TMX Newsfile
Charles River Laboratories to Present at William Blair and Jefferies Conferences 2026 - BioSpace
Charles River Laboratories (CRL) to Present at Key Investor Conf - GuruFocus
Charles River Laboratories to Present at William Blair and Jefferies Conferences - pharmiweb.com
CLSA upgrades Charles River Laboratories International (CRL) - MSN
Charles River Laboratories (CRL) Slides Slightly, Holds Near Key ResistanceMarket Cap Weight - thelegaladvocate.com
Charles River Laboratories Hits Day High with 10.24% Surge in Stock Price - Markets Mojo
CLSA upgrades Charles River Labs stock rating on regulatory outlook - Investing.com UK
CLSA upgrades Charles River Labs stock rating on regulatory outlook By Investing.com - Investing.com Nigeria
[Form 4] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading Activity - Stock Titan
1.63%
2.88%
자본화:
|
볼륨(24시간):